ClinicalTrials.Veeva

Menu

Outcomes of Patients tReated wIth Mitral Transcatheter Edge-to-edge Repair for Primary Mitral Regurgitation Registry (PRIME-MR)

U

Universitätsklinikum Hamburg-Eppendorf

Status

Enrolling

Conditions

Mitral Regurgitation

Study type

Observational

Funder types

Other

Identifiers

NCT05332782
PRIME-MR

Details and patient eligibility

About

This multinational, non-interventional, investigator-initiated, retrospective study aims to investigate outcomes of patients, who underwent mitral valve transcatheter edge-to-edge repair (M-TEER) for primary mitral regurgitation (PMR).

Enrollment

2,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • clinically significant primary mitral regurgitation
  • patient underwent M-TEER
  • echocardiography data at baseline, procedure and follow-up
  • follow-up of at least 12 months

Exclusion Criteria

  • age under 18 years

Trial design

2,000 participants in 1 patient group

M-TEER
Description:
Patients with primary mitral regurgitation undergoing mitral valve transcatheter edge-to-edge repair.

Trial contacts and locations

6

Loading...

Central trial contact

Sebastian Ludwig, MD; Benedikt Koell, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems